Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Production License" and passed the drug GMP compliance inspection
Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., recently obtained a "Drug Production License" approved by the Gansu Provincial Drug Administration and a "Drug GMP Compliance Inspection Notification." The renewed "Drug Production License" is valid until March 2, 2026, with the production address and scope located at No. 1, Nongda North Road, Huangyang Ecological Industrial Demonstration Park, Liangzhou District, Wuwei City, Gansu Province, including decoctions, film preparations, active pharmaceutical ingredients, pretreatment, and extraction, etc. The newly constructed production line for liquid preparations such as the annual output of 50 million boxes of cough syrup has been upgraded and transformed to meet the requirements of the "Drug Production Quality Management Standards" and is ready for production and operation, which is beneficial for further ensuring the market sales and product supply of cough syrup, and has positive significance for the company's future development
